Results 151 to 160 of about 1,931,179 (282)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

NDST: Neural Driving Style Transfer for Human-Like Vision-Based Autonomous Driving [PDF]

open access: yes
Autonomous Vehicles (AV) and Advanced Driver Assistant Systems (ADAS) prioritize safety over comfort. The intertwining factors of safety and comfort emerge as pivotal elements in ensuring the effectiveness of Autonomous Driving (AD).
Kim, Donghyun   +3 more
core   +1 more source

Immersive driving simulation architecture to support gamified eco-driving instructions [PDF]

open access: yes, 2016
Eco-driving is about energy efficient use of vehicles. There are many approaches to improve eco-driving. Eco-driving driving style is hard to learn even with the help of driving assistance systems.
Vaezipour, Atiyeh   +6 more
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Measuring driving styles: A validation of the multidimensional driving style inventory," [PDF]

open access: yes, 2015
The aim of this study was to validate the stability of the different factors of the Multidimensional Driving Style Inventory ...
Eggen}@tue   +14 more
core  

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

open access: yesMolecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic   +15 more
wiley   +1 more source

Interpretation of driving style tips : application of the major driving style tips of "New Style Driving" by passenger car drivers and the effects on fuel consumption and tail pipe emissions

open access: yes, 2002
Besides the applied engine and vehicle technology, the fuel economy of a car is also influenced by the behaviour of its driver. In the order to address the influence of a driver on the fuel consumption of road vehicles, the Dutch government and Novem ...
Burgwal, H.C. van de, Gense, N.L.J.
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy